Although the last two decades have seen significant progress in deciphering disease pathways, dementias such as Alzheimer’s disease remain a major unmet medical need. My work focuses on developing human disease models derived from human induced pluripotent stem cells, which faithfully recapitulate major disease hallmarks. I gene-edit these models with advanced CRISPR/Cas9 technology to elucidate molecular disease players and develop novel treatment strategies.